COVID-19 update included
The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic
Key Findings
The global protein labeling market is expected to catapult ahead over the forecast period of 2018-2026 by exhibiting a CAGR of 14.10%. Factors such as growing demand for proteomics research and genome sequencing and increasing research and development investments are propelling this market’s growth.

Market Insights
The Global Protein labeling market segments include applications, products, and labeling. The application segment is sub-divided into cell-based assay, fluorescence microscopy, mass spectrometry, immunological technique and protein microarray. The products found in the protein labeling market includes reagents, enzymes, protein, monoclonal antibodies, probes/tags, other reagents, kit and services. The labeling segment of this market is sub-divided into in vivo labeling, in vitro labeling and bio-orthogonal labeling.

Regional Insights
North America, Europe, Asia-Pacific and rest of the world are the four main geographies analyzed for the global protein-labelling market. The North American market is expected to account for the highest revenue share by the end of 2026. The U.S market dominates this region. The Asia -Pacific region possesses a high market probable for protein-labeling growth due to an increase in the mandate for drug discovery booming biotechnology industry. As a result, the market is likely to register the highest CAGR over the forecast period.

Competitive Insights
Companies like Active Motif Inc, Agilent Technologies Inc, Bio-Rad Laboratories, Candor Bioscience Gmbh, Caprion Biosciences, F. Hoffmann-La Roche Ag, General Electric Company, Innova Biosciences Ltd, Kaneka Corp, Luminex Corp, Merck & Company Inc, New England Biolabs Inc, Perkinelmer Inc, Promega Corporation, Thermo Fisher Scientific Inc, and Qiagen N.V are operating in this region.